Alere lawsuit accuses Abbott of ‘buyer’s remorse’ in proposed merger

(Reuters) – Alere Inc alleges Abbott Laboratories is trying to stymie its planned $5.8 billion takeover of the diagnostics company by purposefully delaying key submissions to anti-trust regulators, according to a lawsuit made public on Tuesday.